Recombinant Human LCE3B Protein，GST

LCE3B (Late Cornified Envelope 3B) is a member of the LCE gene family, which plays a crucial role in the skin's barrier function and maintains homeostasis. This protein is predominantly expressed in the epidermis, where it contributes to the terminal differentiation of keratinocytes and the formation of the stratum corneum, the outermost layer of skin. LCE3B has garnered attention in dermatological research due to its potential association with various skin disorders, including psoriasis and atopic dermatitis. Studies have indicated that alterations in LCE3B expression may influence inflammation and keratinocyte proliferation, which are pivotal in the pathophysiology of these conditions. Additionally, LCE3B is involved in innate immune responses, suggesting that it may play a role in the skin's defense against microbial pathogens. Recent advancements in recombinant protein technology have enabled the production of LCE3B for further investigation of its functional properties and therapeutic potential. Understanding the structure and activity of LCE3B could lead to novel strategies for treating skin diseases and enhancing skin repair mechanisms. As such, the study of LCE3B recombinant protein serves as a promising avenue for elucidating the molecular mechanisms underlying skin health and disease, with implications for targeted therapies and cosmetic applications.